Search for Content and Resources

Everything was going right for Al Pritchard - he had a young family, a good career and was a healthy athlete. So it came as a shock to be diagnosed with anaplastic large cell lymphoma. His experience taught him a few valuable lessons.

“The majority of people with DLBCL will be cured with their first treatment – so that's a success story,” says Dr. John Kuruvilla, working as a hematologist-oncologist for 20 years including as a researcher in DLBCL, which is the largest form of non-Hodgkin lymphoma.…

Cutaneous T-cell lymphoma (CTCL) is a slow-growing (indolent) subtype of non-Hodgkin lymphoma (NHL). CTCL is rare, representing 4% of NHL cases. It starts in white blood cells (lymphocytes) that reside in the skin, called T-cells.

AITL is a rare, fast-growing (aggressive) T-cell subtype of non-Hodgkin lymphoma (NHL) and a common subtype of peripheral T-cell lymphoma (PTCL). AITL typically affects adults over 50.

In this 1-hour recorded webcast, hematologist-oncologist at the Princess Margaret Cancer Centre in Toronto, and DLBCL researcher, Dr. John Kuruvilla, discusses diagnosis and approach to managing and treating DLBCL, the most commonly diagnosed subtype of non-Hodgkin lymphoma.